Rx0000129 |
Fresenius Kabi USA LLC |
04/24/2025 |
63323069310 |
Acetylcysteine Solution, USP 10% 100mg/mL 10mL Package Quantity 3 |
02/19/2025 |
6.36 |
51.84 |
None |
Non-innovator Multiple Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Price Increase Report is triggered based on 30-day course of therapy. |
Rx0000129 |
Fresenius Kabi USA LLC |
04/24/2025 |
63323069130 |
Acetylcysteine Solution, USP 10% 100mg/mL 30mL Package Quantity 3 |
02/19/2025 |
8.73 |
71.16 |
None |
Non-innovator Multiple Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Price Increase Report is triggered based on 30-day course of therapy. |
Rx0000129 |
Fresenius Kabi USA LLC |
04/24/2025 |
63323069504 |
Acetylcysteine Solution, USP 10% 100mg/mL 4mL Package Quantity 25 |
02/19/2025 |
44.75 |
364.00 |
None |
Non-innovator Multiple Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Price Increase Report is triggered based on 30-day course of therapy. |
Rx0000129 |
Fresenius Kabi USA LLC |
04/24/2025 |
63323069210 |
Acetylcysteine Solution, USP 20% 200mg/mL 10mL Package Quantity 3 |
02/19/2025 |
6.36 |
51.84 |
None |
Non-innovator Multiple Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Price Increase Report is triggered based on 30-day course of therapy. |
Rx0000129 |
Fresenius Kabi USA LLC |
04/24/2025 |
63323069030 |
Acetylcysteine Solution, USP 20% 200mg/mL 30mL Package Quantity 3 |
02/19/2025 |
10.92 |
88.95 |
None |
Non-innovator Multiple Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Price Increase Report is triggered based on 30-day course of therapy. |
Rx0000129 |
Fresenius Kabi USA LLC |
04/24/2025 |
63323036601 |
dimenhyDRINATE Injection Solution 50 MG/ML Package Quantity 25 |
02/19/2025 |
40.25 |
328.50 |
None |
Non-innovator Multiple Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Price Increase Report is triggered based on 30-day course of therapy. |
Rx0000129 |
Fresenius Kabi USA LLC |
04/24/2025 |
63323018410 |
Folic Acid 50mg 10mL MDV Package Quantity 1 |
02/19/2025 |
7.85 |
63.92 |
None |
Non-innovator Multiple Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Price Increase Report is triggered based on 30-day course of therapy. |
Rx0000129 |
Fresenius Kabi USA LLC |
04/24/2025 |
63323059613 |
Glucagon HCl (Diagnostic) Injection Solution Reconstituted 1 MG Package Quantity 10 |
02/19/2025 |
310.30 |
2526.80 |
None |
Single Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Price Increase Report is triggered based on 30-day course of therapy. |
Rx0000129 |
Fresenius Kabi USA LLC |
04/24/2025 |
63323051774 |
Heparin (Porcine) in NaCl Intravenous Solution 25000-0.45 UT/250ML-% Package Quantity 24 |
02/19/2025 |
31.92 |
260.64 |
None |
Innovator Multiple Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Price Increase Report is triggered based on 30-day course of therapy. |
Rx0000129 |
Fresenius Kabi USA LLC |
04/24/2025 |
63323052277 |
Heparin Sodium 25,000USP 500mL Freeflex Inj. in 5% Dextrose Package Quantity 24 |
02/19/2025 |
34.98 |
285.60 |
None |
Innovator Multiple Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Price Increase Report is triggered based on 30-day course of therapy. |
Rx0000129 |
Fresenius Kabi USA LLC |
04/24/2025 |
63323052374 |
Heparin Sodium 5% Dex 25,000USP 250mL Package Quantity 24 |
02/19/2025 |
31.59 |
257.04 |
None |
Innovator Multiple Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Price Increase Report is triggered based on 30-day course of therapy. |
Rx0000129 |
Fresenius Kabi USA LLC |
04/24/2025 |
63323034925 |
Imipenem-Cilastatin Intravenous Solution Reconstituted 250 MG Package Quantity 25 |
02/19/2025 |
52.50 |
427.25 |
None |
Non-innovator Multiple Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Price Increase Report is triggered based on 30-day course of therapy. |
Rx0000129 |
Fresenius Kabi USA LLC |
04/24/2025 |
63323072510 |
Remifentanil Hydrochloride for Inj. 5mg 10mL SDV Package Quantity 10 |
02/19/2025 |
280.70 |
3399.60 |
None |
Non-innovator Multiple Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Price Increase Report is triggered based on 30-day course of therapy. |
Rx0000129 |
Fresenius Kabi USA LLC |
04/24/2025 |
63323046817 |
Sensorcaine 0.25% 10mL SDV (MPF With Epinephrine) Package Quantity 25 |
02/19/2025 |
23.50 |
191.25 |
None |
Non-innovator Multiple Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Price Increase Report is triggered based on 30-day course of therapy. |
Rx0000129 |
Fresenius Kabi USA LLC |
04/24/2025 |
63323046417 |
Sensorcaine 0.25% 10mL SDV (Sterile Pack - MPF) Package Quantity 25 |
02/19/2025 |
14.75 |
178.75 |
None |
Non-innovator Multiple Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Price Increase Report is triggered based on 30-day course of therapy. |
Rx0000129 |
Fresenius Kabi USA LLC |
04/24/2025 |
63323046417 |
Sensorcaine 0.25% 10mL SDV (Sterile Pack - MPF) Package Quantity 25 |
02/19/2025 |
14.75 |
178.75 |
None |
Non-innovator Multiple Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Price Increase Report is triggered based on 30-day course of therapy. |
Rx0000129 |
Fresenius Kabi USA LLC |
04/24/2025 |
63323009330 |
Sodium Chloride 23.4% 120mEq 30mL SDV Package Quantity 25 |
02/19/2025 |
23.50 |
191.25 |
None |
Non-innovator Multiple Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Price Increase Report is triggered based on 30-day course of therapy. |
Rx0000129 |
Fresenius Kabi USA LLC |
04/24/2025 |
63323009561 |
Sodium Chloride 23.4% 400mEq 100mL PBP Package Quantity 20 |
02/19/2025 |
43.20 |
351.40 |
None |
Non-innovator Multiple Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Price Increase Report is triggered based on 30-day course of therapy. |
Rx0000129 |
Fresenius Kabi USA LLC |
04/24/2025 |
63323009020 |
Sodium Chloride Injection Solution 2.5 MEQ/ML Package Quantity 25 |
02/19/2025 |
16.00 |
129.50 |
None |
Non-innovator Multiple Source Drug |
None |
None |
None |
1 |
None |
1 |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Price Increase Report is triggered based on 30-day course of therapy. |